Miromatrix Medical, Inc. (MIRO)
|Net Income (ttm)||-7.79M|
Miromatrix Medical is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives. We have developed a proprietary perfusion technology platform for bioengineering organs that we believe will efficiently scale to address the shortage of available human organs. Our perfusion decellularization and recellularization technology platform includes 118 issued and 35 pending patent applications, with protection in the United States and major markets worldwide. Our... [Read more...]
|IPO Date |
Jun 24, 2021
|Stock Exchange |
|Ticker Symbol |
In 2020, MIRO's revenue was $46,530, a decrease of -81.39% compared to the previous year's $250,000. Losses were -$10.31 million, 154.8% more than in 2019.